71 related articles for article (PubMed ID: 32916710)
21. Who Conducts Health Economic Evaluations of Laboratory Tests? A Scoping Review.
Giusepi I; John AS; Jülicher P
J Appl Lab Med; 2020 Sep; 5(5):954-966. PubMed ID: 32916710
[TBL] [Abstract][Full Text] [Related]
22. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B; Damm O; Beutels P; Bilcke J; Brüggenjürgen B; Gerber-Grote A; Greiner W; Hanquet G; Hutubessy R; Jit M; Knol M; von Kries R; Kuhlmann A; Levy-Bruhl D; Perleth M; Postma M; Salo H; Siebert U; Wasem J; Wichmann O
Pharmacoeconomics; 2016 Mar; 34(3):227-44. PubMed ID: 26477039
[TBL] [Abstract][Full Text] [Related]
23. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.
Augustovski F; Iglesias C; Manca A; Drummond M; Rubinstein A; Martí SG
Pharmacoeconomics; 2009; 27(11):919-29. PubMed ID: 19888792
[TBL] [Abstract][Full Text] [Related]
24. Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating.
van Giessen A; Peters J; Wilcher B; Hyde C; Moons C; de Wit A; Koffijberg E
Value Health; 2017 Apr; 20(4):718-726. PubMed ID: 28408017
[TBL] [Abstract][Full Text] [Related]
25. The methodological quality of health economic evaluations for the management of hip fractures: A systematic review of the literature.
Sabharwal S; Carter A; Darzi LA; Reilly P; Gupte CM
Surgeon; 2015 Jun; 13(3):170-6. PubMed ID: 25523068
[TBL] [Abstract][Full Text] [Related]
26. Systematic Review of Health Economic Evaluations of Diagnostic Tests in Brazil: How accurate are the results?
Oliveira MRF; Leandro R; Decimoni TC; Rozman LM; Novaes HMD; De Soárez PC
Clinics (Sao Paulo); 2017 Aug; 72(8):499-509. PubMed ID: 28954010
[TBL] [Abstract][Full Text] [Related]
27. Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
[TBL] [Abstract][Full Text] [Related]
28. Home treatment for mental health problems: a systematic review.
Burns T; Knapp M; Catty J; Healey A; Henderson J; Watt H; Wright C
Health Technol Assess; 2001; 5(15):1-139. PubMed ID: 11532236
[TBL] [Abstract][Full Text] [Related]
29. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?
Aguiar PM; Lima TM; Storpirtis S
J Clin Pharm Ther; 2016 Apr; 41(2):189-97. PubMed ID: 27009796
[TBL] [Abstract][Full Text] [Related]
30. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
31. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.
Rodgers M; Asaria M; Walker S; McMillan D; Lucock M; Harden M; Palmer S; Eastwood A
Health Technol Assess; 2012 May; 16(28):1-130. PubMed ID: 22642789
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluations in water-fluoridation: a scoping review.
Mariño R; Zaror C
BMC Oral Health; 2020 Apr; 20(1):115. PubMed ID: 32299417
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
[TBL] [Abstract][Full Text] [Related]
34. Cost-utility analyses of diagnostic laboratory tests: a systematic review.
Fang C; Otero HJ; Greenberg D; Neumann PJ
Value Health; 2011 Dec; 14(8):1010-8. PubMed ID: 22152169
[TBL] [Abstract][Full Text] [Related]
35. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease?
Sullivan SM; Tsiplova K; Ungar WJ
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):599-607. PubMed ID: 27659998
[TBL] [Abstract][Full Text] [Related]
36. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
Bereza BG; Machado M; Einarson TR
Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
[TBL] [Abstract][Full Text] [Related]
37. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
Frampton GK; Jones J; Rose M; Payne L
Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
[TBL] [Abstract][Full Text] [Related]
38. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
Heather EM; Payne K; Harrison M; Symmons DP
Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
[TBL] [Abstract][Full Text] [Related]
39. A Systematic Review of the State of Economic Evaluation for Health Care in India.
Prinja S; Chauhan AS; Angell B; Gupta I; Jan S
Appl Health Econ Health Policy; 2015 Dec; 13(6):595-613. PubMed ID: 26449485
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
